
Nearly 700,000 Americans Lose Health Care Coverage in 2025
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Almost 700,000 Americans lost Medicaid coverage in one month at the start of this year, according to new enrollment data compiled by KFF.
The significant drop in Medicaid enrollment in January from December 2024 is part of a long-term trend amid the continuation of the federal program's "unwinding" process, which began after pandemic-era protections ended. Enrollment was still higher in January than it was in February 2020.
Why It Matters
The data highlights the continued ripple effects of the Medicaid policy shift, with millions more likely to be affected in the months ahead—particularly low-income families, children, and older adults who rely on Medicaid for basic care access.
Health care experts and advocates warn that the unwinding process is opening large gaps in the U.S. health care system, with many falling through the cracks due to administrative barriers or lack of communication, not because they no longer qualify.
File photo: people block a street during a protest over proposed cuts to Medicaid funding.
File photo: people block a street during a protest over proposed cuts to Medicaid funding.
Rick Bowmer/AP
What to Know
Data collected by KFF shows that from December 2024 to January 2025, Medicaid enrollment dropped by 669,938, bringing the total number of Americans enrolled in Medicaid to around 71.2 million.
While this number remains high, it reflects a steady monthly decline that began in 2023 when states resumed redeterminations, where they checked whether enrollees were still eligible for benefits.
The process had been paused during the COVID-19 public health emergency alongside an expansion to the federal protection available for vulnerable Americans with limited income and resources.
When those protections were lifted following the pandemic, millions faced the risk of being disenrolled—not just due to income changes, but because of paperwork errors, missed deadlines, or outdated contact information.
According to KFF's data, more than 16 million people have been disenrolled from Medicaid since the unwinding began in the spring of 2023.
An April 2024 survey by KFF of 1,227 U.S. adults who had Medicaid coverage in prior to April 1, 2023, found that 28 percent of former enrolees found other forms of health coverage, while 47 percent were eventually re-enrolled to Medicaid. Around a quarter of enrolees reported as remaining uninsured.
States like Montana, Tennessee and Colorado have seen some of the largest decreases in enrollment, with levels in January 2025 dropping below pre-pandemic levels.
What People Are Saying
William Schpero, assistant professor of population health sciences at Weill Cornell Medicine, told Newsweek: "This is evidence that we are likely still seeing the effects of the end of the continuous coverage provisions in place during the COVID-19 Public Health Emergency that paused redeterminations of Medicaid eligibility. During the 'unwinding' of continuous coverage through September 2024, close to 70 percent of those who lost coverage were disenrolled for purely procedural reasons—for example, they missed a required renewal form because of a change in address. Many of these people likely remained eligible for Medicaid."
He added: "It would be particularly concerning if procedural terminations continue to underlie the latest reported decreases in Medicaid enrollment. It suggests that states can be doing more to prevent avoidable losses of coverage. Research has estimated that a large portion of individuals who have lost Medicaid in recent months have become uninsured or experienced gaps in coverage. We have consistent evidence that loss of Medicaid coverage interrupts access to care — without coverage, people forgo visiting the doctor or taking their prescribed medications due to cost. Ultimately this will hurt health outcomes."
Kathleen Adams, professor of health policy and management at Emory University's Rollins School of Public Health, Georgia, told Newsweek: "We are always concerned with the loss of insurance coverage, especially among the lower income and vulnerable groups traditionally served by Medicaid. If these individuals are not able to find a source of other coverage such as Employer Sponsored Insurance (ESI) or through the subsidized exchanges, they will have lower access to needed health care, face higher costs if they obtain care and could impose costs on the health care system as they are forced to seek care in ERs or other publicly subsidized sources of care."
She added: "The unwinding has taken place over a year and as the report notes, Medicaid enrollment is still higher now than in the pre-pandemic period. It is also important to note the differences seen across states. Some states that had not expanded Medicaid under the ACA did so recently and many of them show the largest increases in enrollment from their pre-pandemic levels. Currently, the concerns with Medicaid enrollment are with the administration's proposed changes to Medicaid eligibility which some states are already seeking to implement."
What's Next
Unless policies change, experts project that millions more Americans may lose health coverage through 2025, not just due to changes in eligibility requirements, but also because of bureaucratic hurdles.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
30 minutes ago
- Newsweek
Map Shows Assisted Dying Laws Across US
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. New York has recently joined a number of other U.S. states that have made assisted dying legal. The state's Senate approved a bill on Monday allowing constituents with terminal diagnoses to end their lives on their own terms, and the legislation is now headed to Governor Kathy Hochul for her to sign into law. There are currently 10 states, as well as the District of Columbia, that have passed laws making medical assistance in dying (MAID) legal, according to Death With Dignity, and a number of others are considering similar legislation this year. Why It Matters Assisted dying laws are extremely divisive and are being considered and sworn into law in various countries across the globe. Those in favor say the legislation allows terminally ill individuals to seek medical assistance in ending their lives under specific conditions, promoting personal autonomy and a relief from suffering. Critics have voiced concern over suicide contagion, a phenomenon where increased exposure to suicide is believed to trigger suicidal behavior in others, and what the legislation means for the deaths of patients struggling with depression. What To Know In the U.S., California, Colorado, Hawaii, Maine, Montana, New Jersey, New Mexico, Oregon, Vermont, and Washington all have legislation in place that enables those in the states to access MAID. Oregon was one of the first countries in the world to establish this form of support for patients and did so in 1997. Since then, other assisted dying laws in the country have utilized the state's legal framework for their own MAID legislation, according to the BBC. New York is not the only state that has been eyeing such legislation, as more than 15 other states have also been deliberating MAID laws this year. These states include Arizona, Connecticut, Delaware, Florida, Illinois, Indiana, Kentucky, Maryland, Massachusetts, Minnesota, Missouri, Nevada, New Hampshire, North Carolina, Pennsylvania, Rhode Island, and Tennessee. In America, for a patient to have access to medically assisted dying, they typically have to be terminally ill and expected to die within six months, under the terms of the "Death with Dignity Act," according to an Oregon government report. They must also be over the age of 18 and capable of making and communicating health care decisions. A patient's request to access MAID services must also be approved by two doctors, and their request must be witnessed by two adults, who have no claim to any form of inheritance in the incidence of the patient's death. Should they feel it necessary, the doctors can refer the patient for a psychiatric evaluation. While MAID laws remain divisive, a Gallup poll conducted last year found that seven in 10 Americans, so 71 percent, believed medical doctors should be "allowed by law to end a patient's life by some painless means if the patient and his or her family request it." What People Are Saying Professor Thaddeus Mason Pope, a professor of law at the Mitchell Hamline School of Law, Minnesota, told Newsweek: "Millions of Americans die every year. Hospice and palliative care can address the physical and existential suffering of most but not all dying patients. MAID is for the small subset whose suffering is refractory to other measures." He added: "Nearly 20 states considered MAID legislation in 2025, and many of these bills made significant progress passing one or both legislative chambers. While fewer than 1 percent use MAID, nearly 75 percent of the public want to have this option. Decades of experience in other states shows a solid patient safety track record. Generally blue states pass MAID legislation and red ones do not. Few expect to see MAID authorized in the South or even the Midwest except for Illinois and Minnesota." Alan Meisel, professor of law Emeritus at the University of Pittsburgh School of Law, Pennsylvania, told Newsweek: "Assisted dying laws allow people who are near the end of life to die in a dignified fashion, without being hooked up to medical machinery which only extends the process of dying, often in a painful way. People have understood how undignified the dying process can be and are seeking to implement laws that have proved highly successful in other states and countries." He added: "The states that have been hesitant to enact such laws are often those with large populations of people whose religious beliefs hold that a scintilla of life, no matter how painful or undignified, must be preserved at all costs. These people are often not in the majority but can be very vocal in opposing such laws and therefore state legislators can be reluctant to enact such laws, even though a majority may support them, because they are afraid of damage to their political careers." What Happens Next As a significant number of states are set to discuss possible MAID legislation in the coming months, there could be an increase in the legalization of the practice in America.


Newsweek
35 minutes ago
- Newsweek
Unexpected Solution Could Help Reduce Sudden Infant Death Syndrome
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A common household chemical might hold a surprising secret—one that could help prevent sudden infant death syndrome (SIDS). In a new paper published in the Journal of Perinatology, researchers at Rutgers Health propose that caffeine—long used as a respiratory stimulant in premature infants—could help protect babies from the low-oxygen episodes that may trigger SIDS and other forms of sudden unexpected infant death (SUID). SIDS remains the leading cause of death for infants between one and 12 months of age. "We've been concerned about why the rates haven't changed," said Dr. Thomas Hegyi, a neonatologist at Rutgers Robert Wood Johnson Medical School and lead author of the study. "So, we wanted to explore new ways of approaching the challenge." Shot of a mother bonding with her baby daughter at home holding a cup of coffee. Shot of a mother bonding with her baby daughter at home holding a cup of coffee. PeopleImages Nearly every known risk factor for SIDS—such as stomach sleeping, exposure to cigarette smoke, bed-sharing and premature birth—shares a physiological common denominator: "intermittent hypoxia", or repeated episodes where the infant's oxygen levels drop dangerously low. "I wondered, what can counter intermittent hypoxia?" Hegyi questioned. The answer? "Caffeine." Caffeine has long been used to treat apnea in premature infants, stimulating breathing and proving safe for newborns, he explained. What makes it even more interesting is how slowly infants metabolize caffeine. In a newborn, caffeine can stay in the system for weeks. That extended presence may help explain a long-standing mystery: why the risk of SIDS peaks between two and four months of age. According to the researchers, caffeine passed from mother to baby—either during pregnancy or through breast milk—may offer early protection that fades as the baby's metabolism speeds up. This idea also opens the door to a potential explanation for the protective effects of breastfeeding, which has long been associated with reduced SIDS risk. "We hypothesize that the protection afforded by breast milk is, in part, due to caffeine," the authors wrote. If proven, this theory would mark a dramatic shift in SIDS prevention strategies—from purely behavioral interventions to the first-ever pharmaceutical approach. But the researchers are careful to note that this is preliminary, hypothesis-generating work—not a call for parents to start giving their babies coffee. "The idea isn't that caffeine will replace risk-reduction behaviors," said paper co-author Dr. Barbara Ostfeld, director of the SIDS Center of New Jersey. "A baby dying from accidental suffocation, one component of SUID, is not likely to have benefited from caffeine but would have from such safe sleep practices as the elimination of pillows and other loose bedding from the infant's sleep environment." Instead, the Rutgers team envisions caffeine as a possible complement to existing recommendations. To test their theory, the researchers plan to analyze caffeine levels in infants who died of SIDS and compare them with those who died from other causes, such as trauma or illness. For over 30 years, Ostfeld and others have been educating New Jersey's parents about safe infant sleep practices, which has helped bring the state's SUID rates to the second lowest in the U.S. "Still, for various reasons, these proven recommendations are not universally adopted," she said. "This new hypothesis offers a way not just to address important risk factors but potentially intervene." Despite decades of outreach and awareness, SIDS rates in the U.S. have refused to budge in recent years. The introduction of caffeine as a preventive measure could revive stalled efforts—and bring renewed hope to parents and researchers alike. "[The goal is] to stimulate new thinking about a problem that has remained unchanged for 25 years," Hegyi concluded. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about SIDS? Let us know via health@ Reference Hegyi, T., & Ostfeld, B. M. (2025). Reducing the risk of sudden unexpected infant death: The caffeine hypothesis. Journal of Perinatology.
Yahoo
43 minutes ago
- Yahoo
Home Medical Equipment Market is expected to grow at a steady CAGR of 4.5% through 2034
Home Medical Equipment MarkeT Outlook, Trends and Forecast to 2034 Luton, Bedfordshire, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- Market Overview The global home medical equipment market is witnessing a transformative shift driven by evolving healthcare delivery models, technological integration, and rising patient preference for at-home care. Valued at approximately USD 45 billion in 2024, the market is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.5%, reaching USD 69 billion by 2034. This steady growth is primarily supported by an aging global population, the increasing prevalence of chronic illnesses, and the subsequent need for cost-effective, home-based health management solutions. Patients and caregivers are increasingly leaning towards home care due to its convenience, affordability, and ability to reduce hospital readmissions. Download PDF Brochure: Key Growth Drivers A significant driver of market expansion is the growing burden of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions. These require ongoing management, often best conducted in the comfort of a patient's home. Additionally, the global demographic shift towards an older population has intensified the demand for home-based care, especially for patients with mobility limitations or long-term conditions. The advancement and adoption of telehealth, Internet of Things (IoT)-enabled devices, and wearable healthcare technology further contribute to this growth. These innovations have made it easier for patients to track their health metrics remotely and for healthcare professionals to monitor progress without physical visits. Enhanced connectivity and patient engagement tools are also driving better clinical outcomes, thus fueling adoption. Market Restraints and Challenges Despite promising growth prospects, the home medical equipment market faces notable hurdles. Regulatory variability across regions poses challenges for device approvals and commercialization. The lack of harmonized standards often leads to delays in product launches and increases compliance costs. Moreover, disparate reimbursement policies across countries complicate the adoption of home medical devices, especially in low-to-middle-income economies where public health coverage is limited. Supply chain disruptions, worsened by global events such as the COVID-19 pandemic and geopolitical tensions, have led to raw material shortages and increased production costs. Moreover, pricing pressures and competition from low-cost manufacturers further strain profit margins, making it difficult for companies to balance affordability and innovation. Segmentation Analysis By Product Type The market is segmented into monitoring and therapeutic devices, mobility assist devices, home respiratory equipment, sleep apnea devices, wound care, IV equipment, and other categories. Monitoring and therapeutic devices dominate the segment, accounting for roughly 30% of the market share. These include glucose monitors, blood pressure monitors, and other devices critical for chronic disease management. Their adoption is fueled by technological integration, especially telehealth compatibility. Mobility assist devices, including wheelchairs and walkers, contribute approximately 20% of the total share. Their demand is closely tied to the aging population and innovations such as lightweight materials and ergonomic designs. Home respiratory equipment, which includes oxygen concentrators and nebulizers, holds an 18% share. The spike in respiratory ailments, including long-term effects of COVID-19, has significantly driven growth in this segment. By End User The homecare settings segment leads the market with around 40% of the demand, driven by growing patient preference for personalized care and economic savings compared to institutional care. Hospitals, although traditionally dominant, now account for 25%, often engaging in partnerships with homecare providers to manage post-discharge care. Rehabilitation centers and long-term care facilities represent about 15%, supported by integrated care models that combine therapeutic and mobility support at home. By Distribution Channel Direct sales channels, where companies sell products directly to consumers or care facilities, account for nearly 30% of the market. This approach offers customized solutions and stronger customer relationships. Online sales, contributing to 28%, are growing rapidly due to consumer convenience and the rising popularity of e-commerce. Meanwhile, retail pharmacies and medical equipment stores together represent about 20%, supported by their accessibility and integration with health services. By Demographics The geriatric population makes up 60% of the market, reflecting their higher demand for home medical equipment due to age-related conditions. Adults, particularly those managing chronic conditions at home, contribute 25%, while the pediatric segment comprises 15%, driven by parental preferences for home-based treatment solutions. Browse full Report - Market Segmentation Product Type: Monitoring and Therapeutic Devices Mobility Assist Devices Home Respiratory Equipment Sleep Apnea Devices Wound Care Equipment Home IV Equipment Other Home Healthcare Equipment End-User: Hospitals Homecare Settings Rehabilitation Centers Long-term Care Facilities Assisted Living Facilities Distribution Channel: Direct Sales Online Sales Retail Pharmacies Medical Equipment Stores Demographics: Age Group (Pediatrics, Adults, Geriatrics) Gender (Male, Female) Socioeconomic Status (Low, Medium, High-income groups) Regional Insights North America leads the global market, contributing approximately 40% of total revenue in 2024. The region benefits from robust healthcare infrastructure, favorable reimbursement policies, and a high prevalence of chronic conditions. Technological adoption is also significantly high, with telemedicine and IoT devices becoming standard in many care settings. North America is projected to maintain a healthy CAGR of 5.5% through 2034. Europe holds around 25% of the global share, led by countries such as Germany and France. The region is characterized by a growing elderly population, supportive homecare policies, and well-established healthcare systems. The forecast CAGR for Europe is 4.8%, driven by demand for remote care solutions and wearable devices. Asia-Pacific, accounting for 20% of market share in 2024, is expected to grow at the fastest CAGR of 7.2%. Key contributors include China, India, and Japan, where rising disposable incomes, healthcare awareness, and investments in healthcare infrastructure are accelerating adoption. However, regulatory complexities and regional disparities remain challenges. Latin America and the Middle East are emerging regions, each showing potential with projected CAGRs of 6.4% and 6.1%, respectively. Improvements in healthcare access, economic reforms, and increased awareness of homecare benefits are aiding growth, though infrastructural and regulatory barriers persist. Key Market Trends and Opportunities An increasing focus on preventive healthcare is shaping demand for home diagnostics and early detection devices. This shift is accompanied by growing interest in wearables, AI-enabled analytics, and remote patient monitoring systems, offering a promising frontier for device manufacturers. New business models, including equipment-as-a-service and subscription-based offerings, are gaining popularity. These provide affordability and flexibility to users while ensuring stable revenue streams for providers. Moreover, partnerships between device manufacturers and digital health platforms are becoming a norm, resulting in integrated care solutions that improve patient adherence and satisfaction. Emerging areas of opportunity include mental health support tools and chronic disease management platforms, both of which require consistent monitoring and therapy that can be effectively managed at home. As healthcare transitions toward a patient-centric model, home medical equipment companies have a unique opportunity to redefine care delivery. Buy Now: Recent Market Developments Key Competitors Philips Healthcare Invacare Corporation Medtronic ResMed Baxter International Inc. Johnson & Johnson Fresenius Medical Care AG & Co. KGaA Hill-Rom Holdings, Inc. Drive DeVilbiss Healthcare Arjo AB GE Healthcare Omron Healthcare SunMed Amedisys Inc. althera Health1. Philips Healthcare Month & Year: October 2023 Type of Development: Product Launch Detailed Analysis: In October 2023, Philips Healthcare launched an innovative range of portable home ventilators aimed at improving respiratory care for patients with chronic obstructive pulmonary disease (COPD). This launch is significant as it responds to an increasing global demand for at-home healthcare solutions, especially post-pandemic, where many patients prefer or are required to manage their health from home. The portable nature of these ventilators facilitates easy transport and increased accessibility, appealing to both consumers and healthcare providers seeking to enhance patient care. As healthcare systems globally pivot towards value-based care models, products like Philips' new ventilators may help drive a competitive edge by offering enhanced patient-centric solutions, thereby potentially increasing market shares among key competitors. This strategic move reflects a trend towards integrating advanced technology in home medical equipment, likely setting new standards for functionality and user experience. 2. Invacare Corporation Month & Year: September 2023 Type of Development: Acquisition Detailed Analysis: Invacare Corporation announced its acquisition of a leading telehealth platform in September 2023, marking a pivotal shift towards digital healthcare integration within home medical equipment. This acquisition aligns with emerging trends that emphasize remote patient monitoring and telehealth services, which have surged in demand since the pandemic. The significance of this move lies in Invacare's commitment to providing comprehensive home care solutions that not only offer medical equipment but also integrate vital telehealth technologies. By enhancing their product offerings to include remote monitoring capabilities, Invacare positions itself to capture a growing segment of the market that values digital health tools. Moreover, this acquisition may prompt competitive shifts, as it encourages other players to innovate and expand their offerings in line with technological advancements, further transforming the home healthcare sector. 3. Medtronic Month & Year: August 2023 Type of Development: Regulatory Approval Detailed Analysis: In August 2023, Medtronic obtained regulatory approval for its latest remote monitoring system, designed for chronic disease management in home settings. This system enables healthcare providers to monitor patient health metrics in real-time, facilitating proactive care interventions. The significance of this approval cannot be overstated, considering the increasing emphasis on reducing hospital readmissions and improving care efficiency. Medtronic's system stands to reshape care pathways by allowing timely decision-making based on comprehensive patient data. With the home healthcare market projected to grow substantially, this advancement could drive competitive advantage, compelling other companies to pursue similar regulatory pathways to enhance their offerings. As the technology gains traction, it may also highlight a shift toward integrated care solutions that leverage data analytics and remote technologies, indicating an evolution in home care's operational model. 4. ResMed Month & Year: July 2023 Type of Development: Partnership Detailed Analysis: July 2023 saw ResMed enter into a strategic partnership with a leading digital health company to enhance sleep apnea treatment through data-driven solutions. The partnership aims to integrate wearable technology to monitor sleep patterns effectively and personalize therapy for patients using ResMed devices. This collaboration is significant as it reflects a growing trend towards integrating artificial intelligence and machine learning into patient care. By leveraging technology, ResMed not only improves treatment efficacy but also elevates patient engagement, making adherence to treatment protocols more intuitive. The collaboration could lead to increased market share and customer loyalty for ResMed, setting a precedent for other players to engage in similar innovative partnerships. Those companies that fail to adopt such integrative approaches may find themselves at a competitive disadvantage as the market increasingly values connected healthcare solutions. 5. Baxter International Inc. Month & Year: June 2023 Type of Development: Expansion Detailed Analysis: In June 2023, Baxter International Inc. announced its expansion into the Asian market with the opening of a new manufacturing facility dedicated to home intravenous therapy products. This move reflects Baxter's strategic focus on growing international revenues amidst increasing local demand for home care solutions. By tapping into the burgeoning Asian economy, which is witnessing a rapid shift towards home healthcare due to its cost-effectiveness and patient preference, Baxter is poised to significantly bolster its market presence. This expansion also signifies a competitive shift, as it may encourage other global players to target emerging markets aggressively. The trend towards localized production not only facilitates faster response times to market demands but also positions companies like Baxter to capitalize on regional healthcare initiatives aimed at reducing hospital overcrowding, thereby influencing the overall landscape of home healthcare products. This report is also available in the following languages : Japanese (在宅医療機器市場), Korean (가정용 의료 장비 시장), Chinese (家庭医疗设备市场), French (Marché des équipements médicaux à domicile), German (Markt für medizinische Geräte für den Heimgebrauch), and Italian (Mercato delle apparecchiature mediche domestiche), etc. Request Sample Pages: More Research Finding – Medical Assistive Technology Market The global medical assistive technology market is valued at approximately $45 billion in 2024, with a projected growth to around $81 billion by 2034. This represents a robust Compound Annual Growth Rate (CAGR) of 6.2% from 2025 to 2034. Orthopedic Rehabilitation Aids Market The global orthopedic rehabilitation aids market is poised to reach an estimated value of approximately $10 billion in 2024, driven by an aging population and increasing incidence of musculoskeletal disorders. During the forecast period from 2025 to 2034, the market is projected to expand at a Compound Annual Growth Rate (CAGR) of 6.8%, potentially reaching around $20 billion by 2034. Rehabilitation Medical Device Market The global rehabilitation medical device market is valued at approximately $19.2 billion in 2024, with projections indicating significant growth to reach around $31.5 billion by 2034. This reflects a robust Compound Annual Growth Rate (CAGR) of around 5.1% during the forecast period from 2025 to 2034. Medical Rehabilitation Equipment Market The global medical rehabilitation equipment market is valued at approximately $14 billion in 2024, with expectations to reach around $25 billion by 2034, indicating a robust growth trajectory. This represents a Compound Annual Growth Rate (CAGR) of about 6.4% from 2025 to 2034. Amyotrophic Lateral Sclerosis Device Market The global market for amyotrophic lateral sclerosis (ALS) devices is valued at approximately $2.1 billion in 2024. This market is anticipated to reach around $3.6 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period from 2025 to 2034. Aid for The Elderly and Disabled Market The global market for aid for the elderly and disabled is projected to reach approximately $95 billion in 2024, with expectations to expand significantly over the next decade. By 2034, the market value is forecasted to soar to around $150 billion, reflecting a robust Compound Annual Growth Rate (CAGR) of approximately 4.7% during the period from 2025 to 2034. Assistive Devices For The Elderly and Disabled Market The global market for assistive devices for the elderly and disabled is valued at approximately $35 billion, with a robust projected growth trajectory. By 2034, this market is anticipated to reach $70 billion, reflecting a Compound Annual Growth Rate (CAGR) of about 7.3%. Stroke Assistive Devices Market The stroke assistive devices market is valued at approximately $2.5 billion in 2024, driven by the increasing prevalence of strokes and a growing geriatric population. This segment is expected to reach around $4.5 billion by 2034, reflecting a robust investment in healthcare infrastructure and advanced rehabilitation solutions. The projected Compound Annual Growth Rate (CAGR) during the forecast period from 2025 to 2034 is estimated at 6.1%. U.S. Physical Therapy Equipment Market The U.S. physical therapy equipment market is valued at approximately $3.2 billion in 2024, with expectations to reach around $5.2 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of about 5.0% during the forecast period from 2025 to 2034. Pulsed Light Medical Equipment Market The global pulsed light medical equipment market is poised for significant growth, with a current valuation of approximately $540 million in 2024. Projecting forward, this market is expected to reach around $1.2 billion by 2034, reflecting robust demand driven by advancements in medical technology and increasing adoption of non-invasive treatment options. The market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of about 8% during the forecast period from 2025 to 2034. Xenon Flash Lamp Market The global xenon flash lamp market is valued at approximately $450 million in 2024, with projections indicating a robust growth trajectory, reaching approximately $675 million by 2034. This represents a compound annual growth rate (CAGR) of around 4.5% over the forecast period from 2025 to 2034. Polarizing Beam Splitters PBS Market The global market for polarizing beam splitters (PBS) is valued at approximately $1.2 billion in 2024, with an anticipated expansion to $2.5 billion by 2034. This growth trajectory suggests a robust Compound Annual Growth Rate (CAGR) of around 8.1% during the forecast period from 2025 to 2034. Special Equipment Manufacturing Market The global special equipment manufacturing market is projected to reach approximately USD 250 billion in 2024. This sector encompasses a diverse array of industries, including construction, mining, and specialized machinery. The market is expected to exhibit robust growth, reaching an estimated value of USD 425 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 5.3% from 2025 to 2034. Plasma Cleaners Market The global plasma cleaners market is valued at approximately $450 million, with projections estimating a market value of around $1.1 billion by 2034. This growth trajectory reflects a Compound Annual Growth Rate (CAGR) of about 9% over the forecast period from 2025 to 2034. Strain Wave Gearing Devices Market The global strain wave gearing devices market is estimated to reach a valuation of approximately USD 550 million in 2024, with a robust projected growth trajectory anticipating a market value of around USD 1.1 billion by 2034. This reflects a notable Compound Annual Growth Rate (CAGR) of approximately 7.2% over the forecast period from 2025 to 2034. Galvanometer Scanners Market The global galvanometer scanners market is expected to reach a value of approximately $250 million in 2024, driven by rising demand across industries such as medical, defense, and manufacturing for precise laser applications and automation. Projections for the market suggest a robust growth trajectory, with a forecasted value of about $450 million by 2034. Pet Medical Equipment Market The global pet medical equipment market is poised for significant growth, with an estimated market value of approximately $1.5 billion in 2024. Forecasts indicate a robust expansion, anticipating the market will reach around $2.9 billion by 2034, driven by increasing pet ownership and rising expenditure on pet healthcare. 5-axis CNC Machine Tool Market The global 5-axis CNC machine tool market is valued at approximately $3.5 billion in 2024, with forecasts indicating significant growth, projecting a market value of around $5.8 billion by 2034. This trajectory suggests a robust Compound Annual Growth Rate (CAGR) of about 5.3% during the forecast period from 2025 to 2034. Coaxial Isolators Market The global coaxial isolators market is valued at approximately $1.2 billion in 2024, with projections indicating it will reach around $1.9 billion by 2034. This growth signals a robust Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period from 2025 to 2034. CONTACT: Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data